Cancer Research UK logo.
SearchDonate
  • Search

A trial of stereotactic body radiotherapy with targeted drug treatment in advanced non small lung cancer (HALT)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Closed

Phase:

Phase 2/3

Details

This trial is for people with advanced non small cell lung cancer that can’t be treated with the aim to cure. And who:

  • have certain changes (mutations) in their lung cancer cells

  • are having a targeted cancer drug

  • have 5 or fewer areas of cancer that have now stopped responding to targeted cancer treatment

Cancer Research UK supports this trial.

Recruitment start: 27 November 2017

Recruitment end: 17 July 2023

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Fiona McDonald

Supported by

Cancer Research UK

European Organisation for Research and Treatment of Cancer (EORTC)

ICR Clinical Trials and Statistics Unit (ICR-CTSU)

NHS England

Radiotherapy Trials Quality Assurance (RTTQA)

Other information

This is Cancer Research UK trial number CRUK/16/020.

Last reviewed: 09 Jan 2026

CRUK internal database number: 15118

Help and support